Cargando…
30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?
Systemic treatment is the standard treatment for unresectable stage III and IV lung cancer. Nevertheless, a 5–10% death rate has been described within 30 days after the last systemic treatment, suggesting that these patient did not benefit. We analysed the 30-day mortality after start of systemic th...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215912/ https://www.ncbi.nlm.nih.gov/pubmed/30406123 http://dx.doi.org/10.1183/23120541.00030-2018 |